The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialMichael E. Nassif, Mikhail Kosiborod, Barry A. Borlaug et al.|Nature Medicine|2021Cited by 599
Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and PeritonitisHeather L. Caslin, John Ryan|Frontiers in Immunology|2018Cited by 69
Lactic Acid Suppresses IL-33–Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α–Dependent miR-155 SuppressionDaniel Abebayehu, John Ryan|The Journal of Immunology|2016Cited by 67
Novel Mechanism for FcϵRI-mediated Signal Transducer and Activator of Transcription 5 (STAT5) Tyrosine Phosphorylation and the Selective Influence of STAT5B over Mast Cell Cytokine ProductionNick Pullen, John Ryan|Journal of Biological Chemistry|2011Cited by 36
IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell FunctionMarcela T Taruselli, John Ryan|The Journal of Immunology|2024Cited by 9